๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

P191 Mucosal healing after clinical remission predicts long-term outcomes in patients with intestinal Behcet's disease

โœ Scribed by Yim, S.M.; Kim, D.H.; Lee, H.J.; Jang, H.W.; Jung, S.H.; Choi, A.R.; Park, S.J.; Hong, S.P.; Kim, T.I.; Kim, W.H.; Cheon, J.H.

Book ID
123561261
Publisher
Oxford University Press
Year
2013
Tongue
English
Weight
53 KB
Volume
7
Category
Article
ISSN
1873-9946

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Prognostic factors and long-term clinica
Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behcet's disease
โœ Yoon Suk Jung; Jin Young Yoon; Jin Ha Lee; Soung Min Jeon; Sung Pil Hong; Tae Il ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 350 KB

Background: To date there have been few studies regarding the efficacy of surgical treatment and related prognostic factors following intestinal resection in patients with intestinal Behcet's disease (BD). Here we investigated the long-term clinical outcomes and related prognostic factors after surg

Mucosal healing predicts long-term outco
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease
โœ Fabian Schnitzler; Herma Fidder; Marc Ferrante; Maja Noman; Ingrid Arijs; Gert V ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 395 KB ๐Ÿ‘ 2 views

Background: Infliximab (IFX) treatment induces mucosal healing (MH) in patients with Crohn's disease (CD) but the impact of MH on the long-term outcome of IFX treatment in CD is still debated. ## Methods: We studied MH during long-term treatment with IFX in 214 CD patients. A total of 183 patients